T. Rowe Price Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.03M Buy
23,791
+16,172
+212% +$1.44M ﹤0.01% 596
2025
Q4
$603K Sell
7,619
-13,033
-63% -$1.02M ﹤0.01% 650
2025
Q3
$1.65M Buy
20,652
+7,636
+59% +$651K ﹤0.01% 624
2025
Q2
$1.18M Buy
13,016
+2,798
+27% +$255K ﹤0.01% 619
2025
Q1
$958K Buy
10,218
+5,204
+104% +$466K ﹤0.01% 618
2024
Q4
$456K Buy
+5,014
New +$478K ﹤0.01% 618

Other funds holding CL

T. Rowe Price Investment Management's CL Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its Colgate-Palmolive (CL) stake by 212% in Q1 2026, buying an estimated $1.44M and bringing the position to 23,791 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #596.

T. Rowe Price Investment Management first reported a position in CL in Q4 2024 and has held it in 6 quarters since. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • T. Rowe Price Investment Management held 23,791 shares of Colgate-Palmolive worth $2.03M as of Q1 2026.
  • T. Rowe Price Investment Management bought 16,172 Colgate-Palmolive shares in Q1 2026, an estimated $1.44M.
  • Colgate-Palmolive made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #596 holding.
  • T. Rowe Price Investment Management first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 6 quarters since.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.